Skip to main content
. Author manuscript; available in PMC: 2011 Apr 1.
Published in final edited form as: Am J Surg. 2010 Apr;199(4):542–548. doi: 10.1016/j.amjsurg.2009.11.002

Figure 5.

Figure 5

CsA treatment prevents cytochrome c release to the cytoplasm in rat lung microvascular endothelial cells (RLMEC) whereas CIP treatment shows no effect. Cytosolic cytochrome c levels are increased following BAK (BH3) transfection compared with control (*p < 0.05; n = 5). CsA pre-treatment in BAK (BH3) transfected cells shows significant decrease in cytochrome c levels compared with BAK (BH3) transfected cells without CsA pre-treatment or with CIP treated-BAK transfected cells (†p < 0.05; n = 5).